Back to Top
Go Back
Journal Photo for Cancer Biology & Therapy
Peer reviewed only Open Access

Cancer Biology & Therapy (CBT)

Publisher : Taylor & Francis
Cancer Biology & Therapy exchange of information Pharmacogenomics
Claim Your Journal Get PRC Visit Website
e-ISSN 1555-8576
p-ISSN 1538-4047
Issue Frequency Continuously
Impact Factor 4.4
Est. Year 2002
Mobile 4402080520500
DOI YES
Country India
Language English
APC YES
Impact Factor Assignee google scholar
Email enquiries@taylorandfrancis.com

Journal Descriptions

Cancer Biology & Therapy is a high-profile international journal examining all aspects of the molecular basis of cancer, with translational relevance to diagnosis and therapy. The goal is to foster communication and the rapid exchange of information through timely publication of important advances within the field. Topics covered include: Existing and emerging technologies such as genome sequencing to increase understanding of genomic and proteomic alterations occurring within tumors; Tumor pathogenesis, development and progression; Drug-drug interactions; mechanisms of action for novel agents; combination chemotherapy; Pharmacogenomics, pharmacodynamics, and pharmacokinetic properties of anticancer agents; Anticancer chemotherapeutic agents, biological agents, immunomodulatory drugs, cell therapy and gene therapy.

Cancer Biology & Therapy (CBT) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Cancer Biology & Therapy, exchange of information, Pharmacogenomics, pharmacodynamics, pharmacokinetic properties of anticancer, relevance to diagnosis and therapy, research, reviews, meeting reports, bedside-to-bench reports, letters to the editor , Online or Print , Continuously Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1538-4047, E-ISSN: 1555-8576, Established: 2002, Impact Factor: 4.4
  • Provides Crossref DOI

  • Indexed in: Scopus, WoS

  • Not indexed in DOAJ, PubMed, UGC CARE

Indexing

Publications of CBT

First-line treatments for KRAS-mutant non-small cell lung cancer: current state and future perspectives
Mengzhao Wang December, 2024
KRAS mutations are common in non-small cell lung cancer (NSCLC) and are associated with patient prognosis; however, targeting KRAS has faced various difficulties. Currently, immunotherapy, c...
Long-term effects of neoadjuvant chemotherapy in variant histology locally advanced colon cancer: a propensity score-matched analysis
Kuan Wang December, 2024
Purpose Neoadjuvant chemotherapy (NAC) has proven valuable in treating locally advanced colon cancer (LACC) and is included as a treatment option for patients with clinical T4b colon cancer...
Daurisoline inhibits glycolysis of lung cancer by targeting the AKT-HK2 axis
Xin-Xing Wan December, 2024
Lung cancer, one of the most prevalent tumors, remains a clinical challenge with a poor five-year survival rate. Daurisoline, a bis-benzylisoquinoline alkaloid derived from the traditional C...
Knockdown of NDUFAF6 inhibits breast cancer progression via promoting mitophagy and apoptosis
Shang Wu December, 2024
Background While NDUFAF6 is implicated in breast cancer, its specific role remains unclear. Methods The expression levels and prognostic significance of NDUFAF6 in breast cancer were as...
Effect of extracellular vesicle ZNF280B derived from lung cancer stem cells on lung cancer progression
Yuehua Liu January, 2025
Objective The purpose of this research was to investigate the role of extracellular vesicles derived from lung cancer stem cells (lung CSCs-EVs) in lung cancer and to explore their potentia...
NVP-2, in combination with Orlistat, represents a promising therapeutic strategy for acute myeloid leukemia
Peifang Xiao January, 2025
Cell cycle dysregulation and the corresponding metabolic reprogramming play significant roles in tumor development and progression. CDK9, a kinase that regulates gene transcription and cell ...
RSK4 promotes the metastasis of clear cell renal cell carcinoma by activating RUNX1-mediated angiogenesis
Linni Fan January, 2025
Ribosomal S6 protein kinase 4 (RSK4), a member of the serine‒threonine kinase family, plays a vital role in the Ras‒MAPK pathway. This kinase is responsible for managing several cellular...
Sigma1 inhibitor suppression of adaptive immune resistance mechanisms mediated by cancer cell derived extracellular vesicles
Felix J. January, 2025
Adaptive immune resistance in cancer describes the various mechanisms by which tumors adapt to evade anti-tumor immune responses. IFN-γ induction of programmed death-ligand 1 (PD-L1) was th...
Fractionated radiotherapy initiated at the early stage of bone metastasis is effective to prolong survival in mouse model
Xiangmei Zhang January, 2025
Background and purpose Bone metastasis is common for breast cancer and associated with poor prognosis. Currently, radiotherapy (RT) serves as the standard treatment for patients exhibiting ...
miR-301a-mediated crosstalk between the Hedgehog and HIPPO/YAP signaling pathways promotes pancreatic cancer
Jun Gao January, 2025
Pancreatic ductal adenocarcinoma (PDAC) poses a significant challenge in oncology due to its dismal prognosis and limited therapeutic options. In this study, we investigated the role of miR-...